Mod­er­na plays Big Phar­ma ball with CEO pay, push­ing bil­lion­aire Ban­cel in­to the ma­jor leagues

Chang­ing the world with a dis­rup­tive new vac­cine tech­nol­o­gy pays well.

Mod­er­na’s rev­o­lu­tion­ary role in pro­vid­ing the world — or at least the most af­flu­ent parts of it — with a high­ly ef­fec­tive mR­NA jab for Covid-19 set the stage for CEO Stéphane Ban­cel’s pay to rise up to more than $18 mil­lion for last year, ac­cord­ing to a new proxy fil­ing.

Break­ing it down, Ban­cel’s pay in­cludes a $1 mil­lion salary, a $1.5 mil­lion in­cen­tive pack­age and stock and op­tion awards of $15 mil­lion, leav­ing him with the kind of in­come that would com­pare fa­vor­ably with any of the top 15 Big Phar­ma CEOs in the world — and well above what most of the Eu­ro­pean top ex­ecs make, aside from Pas­cal So­ri­ot at As­traZeneca, who came out of last year with his own per­son­al­ized set of brag­ging rights.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER